Quantitative proton magnetic resonance spectroscopy of the subcortical white matter in motor neuron disease

Amyotrophic Lateral Sclerosis

Volumn 1, Issue 2, 2000, Pages 123-129

  Ellis, C M ^a   Simmons A , ^a,b   Glover A , ^b   Dawson, J M ^a,b   Williams, S C R ^a,b   Leigh, P N ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

magnetic resonance spectroscopy; motor neuron disease; subcortical

Indexed keywords

PROTON;

ADULT; AGED; ARTICLE; BRAIN; CLINICAL TRIAL; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MOTOR NEURON DISEASE; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ADULT; AGED; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NERVE FIBERS; PROTONS;

EID: 0034158175     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820050515421     Document Type: Article

References (44)

1. Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994; 44: 1933-1938. (Pubitemid 24319224)
2. Jones AP, Gunawardena WJ, Coutinho CMA, Gatt JA, Shaw IC, Mitchell JD. Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amyotrophic lateral sclerosis). J Neurol Sci 1995; 129: 85-89.
3. Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin M. Quantification of brain metabolites in amy- otrophic lateral sclerosis by localised proton magnetic resonance spectroscopy. Neurology 1997; 48: 878-881.
4. Rooney W, Miller RD, Gelinas D et al. Decreased N-acetyl aspartate in motor cortex and corticospinal tract in ALS. Neurology 1998; 50: 1800-1805. (Pubitemid 28283255)
5. Block W, Karitzsky J, Traber F et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease. Arch Neurol 1998; 55: 931-936. (Pubitemid 28335111)
6. Pan JW, Hoby P, Hetherington J et al. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T. Magn Reson Med 1996; 36: 72-77. (Pubitemid 26196534)
7. Lazareff JA, Olmstead C, Bockhorst KH, Alger JR. Proton magnetic resonance spectroscopic imaging of paediatric low-grade astrocytomas. Childs Nerv Syst 1996; 12: 130-135. (Pubitemid 26107753)
8. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34: 721-727.
9. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. NeuroReport 1998; 9: 1757-1761. (Pubitemid 28289180)
10. Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SCR, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical indings. Neurology 1998; 51: 1104-1109. (Pubitemid 28473408)
11. Brooks BR. World Federation of Neurology Research Group on Neuromuscular Disorders. J Neurol Sci 1994; 124: 96-107.
12. Hillel AD, Miller RD, Yorkston K, McDonald E, Norris FH, Konikao N. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 1989; 8: 142-150. (Pubitemid 19108757)
13. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 1994; 241: 354-371. (Pubitemid 24172331)
14. Howe FA, Maxwell RJ, Saunders DE, Brown MM, Grifiths JR. Proton spectroscopy in vivo. Magn Reson Q 1993; 9: 31-59.
15. Simmons A, Smail M, Moore E, Williams SCR. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain. Magn Reson Imaging 1998; 16: 319-330. (Pubitemid 28264528)
16. +. J Neurochem 1994; 62: 2349-2355. (Pubitemid 24179518)
17. Tallan HH. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem 1957; 224: 41-45.
18. Miyake M, Kakimoto Y, Sorimachi M. A gas chromato-graphic method for the determination of N-acetyl-L-aspartic acid, N-acetyl-α-aspartylglutamic acid and α-citryl-L-glu-tamic acid and their distributions in the brain and other organs of various species of animals. J Neurochem 1981; 36: 804-810. (Pubitemid 11100060)
19. Whittingham TS, Douglas A, Holtzman D. Creatine and nucleotide triphosphates in rat cerebral grey and white matter. Metab Brain Dis 1995; 10: 347-352. (Pubitemid 26042542)
20. Erecinska M, Silver IA. ATP and brain function. J Cereb Blood Flow Metab 1989; 9: 2-19. (Pubitemid 19053430)
21. Pouwels PJW, Frahm J. Regional metabolite concentrations as determined by quantitative localised proton MRS. Magn Reson Med 1998; 39: 53-60. (Pubitemid 28028338)
22. Soher BJ, van Zigl PCM, Duyn JH, Barker PN. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996; 35: 356-363. (Pubitemid 26072107)
23. Doyle TJ, Bedell BJ, Narayana PA. Relative concentrations of proton MR visible neurochemicals in grey and white matter in human brain. Magn Reson Med 1995; 33: 755-759.
24. Wang Y, Li SJ. Differentiation of metabolite concentrations between grey matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy. Magn Res Med 1998; 39: 28-33. (Pubitemid 28028335)
25. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identiies different neural cell types. J Neurosci 1993; 13: 981-989. (Pubitemid 23067586)
26. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 1994; 44: 1411-1417. (Pubitemid 24247428)
27. Chang L, Ernst T, Osborn D, Seltzer W, Leonido-Yee M, Poland RE. Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. Arch Neurol 1998; 55: 305-311. (Pubitemid 28146195)
28. Chang L, Ernst T, Tornatore C et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 1997; 48: 836-845.
29. Kushner PD, Stephensen DT, Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol 1991; 50: 263-277.
30. Brown P. Pathophysiology of spasticity. J Neurol Neurosurg Psychiatry 1994; 57: 773-777. (Pubitemid 24214953)
31. Travis AM. Neurological deiciencies after ablation of the precentral motor area in Macaca mulatta. Brain 1955; 78: 155-173.
32. Gilman S, Marco LA, Ebel HC. Effects of medullary pyrami-dotomy in the monkey. II. Abnormalities of spindle afferent responses. Brain 1973; 94: 515-530.
33. Cannon BW, Beaton LE, Ranson SW. Nature of paresis following lateral corticospinal section in monkeys. J Neurophysiol 1943; 6: 425-430.
34. Davie CA, Hawkins CP, Barker GJ et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49-58. (Pubitemid 24103384)
35. Clarke DD, Greenfield S, Dicker E, Tirri LJ, Ronan EJ. A relationship of N-acetylaspartate biosynthesis to neuronal protein synthesis. J Neurochem 1975; 24: 479-485.
36. Cangro CB, Namboodiri MA, Sklar LA, Corigliano-Murphy A, Neale JH. Immunohistochemistry and biosynthesis of N-acetylaspartylglutamate in spinal sensory ganglia. J Neurochem 1987; 49: 1579-1588. (Pubitemid 17161382)
37. Lee JH, Arcinue E, Ross BD. Brief report: organic osmolytes in the brain of an infant with hypernatraemia. N Engl J Med 1994; 331: 439-442. (Pubitemid 24247400)
38. Truckenmiller ME, Namboodiri MA, Brownstein MJ, Neale JH. N-acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J Neurochem 1985; 45: 1658-1662. (Pubitemid 16252611)
39. Clark JB. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 1998; 20: 271-276.
40. Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing a wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995; 676: 25-40.
41. Kong J, Zuoshang X. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 1998; 18: 3241-3250. (Pubitemid 28186017)
42. Sasaki S, Iwata M. Ultrastructural study of synapses in the anterior horn cells of patients with amyotrophic lateral sclerosis. Neurosci Lett 1996; 204: 53-56. (Pubitemid 26053674)
43. Comi GP, Bordoni A, Salani S et al. Cytochrome c oxidase subunit 1 microdeletion in a patient with motor neuron disease. Ann Neurol 1998; 43: 110-116. (Pubitemid 28124656)
44. Kuzniecky R, Hetherington H, Pan J et al. Proton spectroscopic imaging at 4.1 Tesla in patients with malformations of cortical development and epilepsy. Neurology 1997; 48: 1018-1024.